Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing
Abstract Broadly neutralizing antibodies (bNAbs) targeting the HIV-1 envelope glycoprotein (Env) have the capacity to delay viral rebound when administered to people with HIV-1 (PWH) during anti-retroviral therapy (ART) interruption. To further enhance the performance of bNAbs through their Fc effec...
Автори: | Steven W. de Taeye, Angela I. Schriek, Jeffrey C. Umotoy, Marloes Grobben, Judith A. Burger, Rogier W. Sanders, Gestur Vidarsson, Manfred Wuhrer, David Falck, Neeltje A. Kootstra, Marit J. van Gils |
---|---|
Формат: | Стаття |
Мова: | English |
Опубліковано: |
Nature Portfolio
2024-08-01
|
Серія: | Communications Biology |
Онлайн доступ: | https://doi.org/10.1038/s42003-024-06659-8 |
Схожі ресурси
Схожі ресурси
-
PP 8.8 – 00129 Antibody mediated killing of HIV-1 infected cells with glycoengineered broadly neutralizing antibodies
за авторством: S. De Taeye, та інші
Опубліковано: (2022-12-01) -
A functional spleen contributes to afucosylated IgG in humans
за авторством: Iwona Wojcik, та інші
Опубліковано: (2021-12-01) -
Acquisition of Fc-afucosylation of PfEMP1-specific IgG is age-dependent and associated with clinical protection against malaria
за авторством: Mary Lopez-Perez, та інші
Опубліковано: (2025-01-01) -
Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions
за авторством: Angela I. Schriek, та інші
Опубліковано: (2022-11-01) -
Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions
за авторством: Angela I. Schriek, та інші
Опубліковано: (2022-05-01)